Screener
ARS Pharmaceuticals, Inc. SPRY Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Revenue Under Collaboration Agreements | $57K-97.8% | $2.49M+1,085% | $6.86M-91.4% | $55K-96.3% | $2.59M+419% | |
| Revenue Under Supply Agreements | $7.39M+2,188% | $2.74M— | $901K+147% | $1.15M— | $323K— | |
| Revenue by Geography | ||||||
| DK | $2.99M+3.7% | $2.78M+1,222% | —— | —— | $2.88M— | |
| JP | $3.37M— | —— | —— | —— | —— | |
| Non Us | $4.08M+11,909% | $2.45M— | —— | —— | $34K-99.8% | |
| US | $26.21M+105% | $17.45M+125% | —— | —— | $12.8M+606% |
FAQ
- How does ARS Pharmaceuticals, Inc. break its business down?
- ARS Pharmaceuticals, Inc. (SPRY) reports revenue by product across 2 parts — Revenue Under Collaboration Agreements and Revenue Under Supply Agreements. Each is extracted from the segment footnotes and tracked over time.
- Where does ARS Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ARS Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
